Case number 1:20-cv-00434
Mallinckrodt Hospital Products IP Limited et al v. Baxter Healthcare Corporation > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 16, 2021 | 12 | Patent/Trademark Report to Commissioner (5) Docket Text: Report to the Commissioner of Patents and Trademarks. (ntl) |
| Apr 30, 2020 | 11 | Order (4) Docket Text: Consent Judgment and Order of Permanent Injunction, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 4/28/20. (ntl) |
| Apr 27, 2020 | 10 | Proposed Consent Judgment (4) Docket Text: PROPOSED CONSENT JUDGMENT and Order of Permanent Injunction by Mallinckrodt Hospital Products IP Limited, Mallinckrodt Hospital Products Inc., New Pharmatop L.P.. (Tigan, Jeremy) |
| Apr 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Plaintiffs' Complaint to July 20, 2020 filed by Baxter Healthcare Corporation. Signed by Judge Leonard P. Stark on 4/2/20. (ntl) |
| Apr 1, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Apr 1, 2020 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Plaintiffs' Complaint to July 20, 2020 - filed by Baxter Healthcare Corporation. (Rovner, Philip) |
| Mar 30, 2020 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Mallinckrodt Hospital Products Inc., Mallinckrodt Hospital Products IP Limited, New Pharmatop L.P.. Baxter Healthcare Corporation served on 3/30/2020, answer due 4/20/2020. (Tigan, Jeremy) |
| Mar 27, 2020 | 1 | Exhibit A-F (94) |
| Mar 27, 2020 | 1 | Civil Cover Sheet (2) |
| Mar 27, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Mar 27, 2020 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,992,218 B2 ;9,399,012 B2 ;9,610,265 B2 ;9,987,238 B2 ;10,383,834 B2. (lak) |
| Mar 27, 2020 | 4 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/20/2020. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 8/20/2028. (lak) |
| Mar 27, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mallinckrodt plc. for Mallinckrodt Hospital Products IP Limited filed by Mallinckrodt Hospital Products IP Limited. (lak) |
| Mar 27, 2020 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mallinckrodt plc. for Mallinckrodt Hospital Products Inc. filed by Mallinckrodt Hospital Products Inc. (lak) |
| Mar 27, 2020 | 7 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by New Pharmatop L.P.. (lak) |
| Mar 27, 2020 | 1 | Complaint* (1) |
